| |
|
Global Hepatitis Summit - Efficacy and Safety of Elbasvir/Grazoprevir in People With Hepatitis C Virus Infection Aged 35 Years or Younger
|
| |
| |
Reported by Jules Levin
Global Hepatitis Summit - 16th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) Global Hepatitis Summit 2018; Toronto, Canada; June 14-17, 2018.
Tarik Asselah1, Stefan Zeuzem2, Nancy Reau3, Peggy Hwang4, Jianmin Long4, Rohit Talwani4, Michael N. Robertson4, Barbara A. Haber4
1Department of Hepatology, Hôpital Beaujon, Clichy, France; 2Goethe University Hospital, Frankfurt, Germany; 3Rush University Medical Center,
Chicago, Illinois, USA; 4Merck & Co., Inc., Kenilworth, New Jersey, USA
| |
| |
| |
|
|
|
